EVE Stock Overview
Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Evolva Holding SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF0.94 |
| 52 Week High | CHF19.00 |
| 52 Week Low | CHF0.62 |
| Beta | 0.20 |
| 1 Month Change | -7.45% |
| 3 Month Change | 40.06% |
| 1 Year Change | -94.78% |
| 3 Year Change | -98.02% |
| 5 Year Change | -98.36% |
| Change since IPO | -99.70% |
Recent News & Updates
Recent updates
We Think Evolva Holding (VTX:EVE) Has A Fair Chunk Of Debt
Nov 21
Would Evolva Holding (VTX:EVE) Be Better Off With Less Debt?
Jun 09Evolva Holding SA (VTX:EVE) Screens Well But There Might Be A Catch
May 05Is Evolva Holding (VTX:EVE) Using Debt In A Risky Way?
Mar 22Is Evolva Holding (VTX:EVE) Weighed On By Its Debt Load?
Dec 01Shareholders Will Probably Hold Off On Increasing Evolva Holding SA's (VTX:EVE) CEO Compensation For The Time Being
Apr 01Evolva Holding's (VTX:EVE) Shareholders Are Down 70% On Their Shares
Feb 13We're Keeping An Eye On Evolva Holding's (VTX:EVE) Cash Burn Rate
Dec 21
Shareholder Returns
| EVE | CH Chemicals | CH Market | |
|---|---|---|---|
| 7D | 0.2% | 1.8% | 1.0% |
| 1Y | -94.8% | 10.5% | -2.5% |
Return vs Industry: EVE underperformed the Swiss Chemicals industry which returned 8% over the past year.
Return vs Market: EVE underperformed the Swiss Market which returned -2.8% over the past year.
Price Volatility
| EVE volatility | |
|---|---|
| EVE Average Weekly Movement | 17.6% |
| Chemicals Industry Average Movement | 3.0% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in CH Market | 7.3% |
| 10% least volatile stocks in CH Market | 2.0% |
Stable Share Price: EVE's share price has been volatile over the past 3 months.
Volatility Over Time: EVE's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of Swiss stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 49 | n/a | www.evolva.com |
Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. It offers various ingredients comprising Veri-te Resveratrol, a nature made ingredient via fermentation that occurs naturally in grapes and other plants, including peanuts, cranberries, and berries; L-Arabinose, a flavoring agent used in Maillard reaction; Valencene, an aroma component of citrus fruit and citrus-derived odorants; Nootkatone, an aroma ingredient of grapefruit obtained via biochemical oxidation of valencene; and Vanillin, a primary component of vanilla bean extract. The company was founded in 2004 and is headquartered in Reinach, Switzerland.
Evolva Holding SA Fundamentals Summary
| EVE fundamental statistics | |
|---|---|
| Market cap | CHF6.81m |
| Earnings (TTM) | -CHF101.22m |
| Revenue (TTM) | CHF4.16m |
1.6x
P/S Ratio-0.1x
P/E RatioIs EVE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EVE income statement (TTM) | |
|---|---|
| Revenue | CHF4.16m |
| Cost of Revenue | CHF0 |
| Gross Profit | CHF4.16m |
| Other Expenses | CHF105.37m |
| Earnings | -CHF101.22m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -14.04 |
| Gross Margin | 100.00% |
| Net Profit Margin | -2,434.99% |
| Debt/Equity Ratio | 0% |
How did EVE perform over the long term?
See historical performance and comparison